The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
EMED · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | AMPH | EMED | MTEX | COLL |
|---|---|---|---|---|
| Moat Score (0–100) | 58 | 59 (highest) | 58 | 58 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 95 (highest) | 63 | 15 | 66 |
| Pricing power | 62 | 99 | 100 (highest) | 67 |
| Returns on capital | 19 | — | 84 | 100 (highest) |
| Balance-sheet safety | 32 (highest) | 28 | 28 | 28 |
| Capital allocation | 83 (highest) | 44 | 64 | 28 |
| 36% below value if growth stopped today | No price data | No price data | 49% below value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $854M | $46329 | $8.6M | $1.1B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2023 | FY2025 | FY2025 |